APA (7th ed.) Citation

Bighetti, S., Bettolini, L., Maronese, C. A., Macchi, F., Fratton, Z., Maione, V., . . . Rossi, M. (2026). Dupilumab-Related Ocular Surface Disease in Atopic Dermatitis: Risk Stratification, Monitoring, and Persistence-Preserving Management. Journal of Clinical Medicine, 15(4), 1651. https://doi.org/10.3390/jcm15041651

Chicago Style (17th ed.) Citation

Bighetti, Stefano, et al. "Dupilumab-Related Ocular Surface Disease in Atopic Dermatitis: Risk Stratification, Monitoring, and Persistence-Preserving Management." Journal of Clinical Medicine 15, no. 4 (2026): 1651. https://doi.org/10.3390/jcm15041651.

MLA (9th ed.) Citation

Bighetti, Stefano, et al. "Dupilumab-Related Ocular Surface Disease in Atopic Dermatitis: Risk Stratification, Monitoring, and Persistence-Preserving Management." Journal of Clinical Medicine, vol. 15, no. 4, 2026, p. 1651, https://doi.org/10.3390/jcm15041651.